Rheumatoid Arthritis Drugs Being Developed: Mayo Clinic Report

According to Mayo Clinic, "researchers are discovering new ways to treat arthritis" and are focused on several new areas. Biologic Response Modifiers being investigated include:

• Tacrolimus (Prograf)
• Rituximab (Rituxan)
• Actemra (Tocilizumab) Interleukin-6 blockers
• Orencia (Costimulation blockers)

Antibiotic treatment and gene therapy are also being investigated. Read more from Mayo Clinic about rheumatoid arthritis drugs in development.

Related Resources - Rheumatoid Arthritis

• Guide to Rheumatoid Arthritis
• Rheumatoid Arthritis Screening Quiz
• Rheumatoid Arthritis: Explained With Pictures
• Test Your Knowledge: Rheumatoid Arthritis
• Fast Facts About Rheumatoid Arthritis
• Rheumatoid Arthritis 101: Free E-Course Newsletter